Literature DB >> 20504887

Early events governing memory CD8+ T-cell differentiation.

Joshua J Obar1, Leo Lefrançois.   

Abstract

Understanding the regulation of the CD8(+) T-cell response and how protective memory cells are generated has been intensely studied. It is now appreciated that a naive CD8(+) T cell requires at least three signals to mount an effective immune response: (i) TCR triggering, (ii) co-stimulation and (iii) inflammatory cytokines. Only recently have we begun to understand the molecular integration of those signals and how early events regulate the fate decisions of the responding CD8(+) T cells. This review will discuss the recent findings about both the extracellular and intracellular factors that regulate the destiny of responding CD8(+) T cells.

Entities:  

Mesh:

Year:  2010        PMID: 20504887      PMCID: PMC2908475          DOI: 10.1093/intimm/dxq053

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  91 in total

1.  CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.

Authors:  Joshua J Obar; Michael J Molloy; Evan R Jellison; Thomas A Stoklasek; Weijun Zhang; Edward J Usherwood; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

2.  Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.

Authors:  Verena Semmling; Veronika Lukacs-Kornek; Christoph A Thaiss; Thomas Quast; Katharina Hochheiser; Ulf Panzer; Jamie Rossjohn; Patrick Perlmutter; Jia Cao; Dale I Godfrey; Paul B Savage; Percy A Knolle; Waldemar Kolanus; Irmgard Förster; Christian Kurts
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

Review 3.  Memory CD8+ T cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Authors:  Victor Peperzak; Yanling Xiao; Elise A M Veraar; Jannie Borst
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

5.  Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation.

Authors:  Caryll Waugh; Linda Sinclair; David Finlay; Jose R Bayascas; Doreen Cantrell
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

Review 6.  The cunning little vixen: Foxo and the cycle of life and death.

Authors:  Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-08-23       Impact factor: 25.606

7.  Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.

Authors:  Matthew E Pipkin; Jilian A Sacks; Fernando Cruz-Guilloty; Mathias G Lichtenheld; Michael J Bevan; Anjana Rao
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

8.  Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.

Authors:  Vandana Kalia; Surojit Sarkar; Shruti Subramaniam; W Nicholas Haining; Kendall A Smith; Rafi Ahmed
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

9.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.

Authors:  Rajesh R Rao; Qingsheng Li; Kunle Odunsi; Protul A Shrikant
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

10.  Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes.

Authors:  David K Finlay; Linda V Sinclair; Carmen Feijoo; Caryll M Waugh; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more
  41 in total

1.  DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.

Authors:  Doris Lambracht-Washington; Bao-Xi Qu; Min Fu; Larry D Anderson; Olaf Stüve; Todd N Eagar; Roger N Rosenberg
Journal:  Cell Mol Neurobiol       Date:  2011-04-06       Impact factor: 5.046

2.  Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection.

Authors:  Shailendra B Tallapaka; Bala V K Karuturi; Pravin Yeapuri; Stephen M Curran; Yogesh A Sonawane; Joy A Phillips; D David Smith; Sam D Sanderson; Joseph A Vetro
Journal:  Int J Pharm       Date:  2019-05-08       Impact factor: 5.875

3.  Paracrine costimulation of IFN-γ signaling by integrins modulates CD8 T cell differentiation.

Authors:  Matthew F Krummel; Jagdish N Mahale; Lion F K Uhl; Emily A Hardison; Adriana M Mujal; Julie M Mazet; Robert J Weber; Zev J Gartner; Audrey Gérard
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

4.  Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner.

Authors:  Bala V K Karuturi; Shailendra B Tallapaka; Pravin Yeapuri; Stephen M Curran; Sam D Sanderson; Joseph A Vetro
Journal:  Mol Pharm       Date:  2017-04-03       Impact factor: 4.939

Review 5.  Regional and mucosal memory T cells.

Authors:  Brian S Sheridan; Leo Lefrançois
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

6.  Distinct mechanisms mediate naive and memory CD8 T-cell tolerance.

Authors:  Evan R Jellison; Michael J Turner; David A Blair; Elizabeth G Lingenheld; Li Zu; Lynn Puddington; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

Review 7.  Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.

Authors:  Stefan Ebert; Jürgen Podlech; Dorothea Gillert-Marien; Kerstin M Gergely; Julia K Büttner; Annette Fink; Kirsten Freitag; Doris Thomas; Matthias J Reddehase; Rafaela Holtappels
Journal:  Med Microbiol Immunol       Date:  2012-09-13       Impact factor: 3.402

8.  CD11a regulates effector CD8 T cell differentiation and central memory development in response to infection with Listeria monocytogenes.

Authors:  Tina O Bose; Quynh-Mai Pham; Evan R Jellison; Juliette Mouries; Christie M Ballantyne; Leo Lefrançois
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

9.  High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion.

Authors:  Samuel Amoah; Beth C Holbrook; Rama D Yammani; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

10.  Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells.

Authors:  Audrey Gérard; Omar Khan; Peter Beemiller; Erin Oswald; Joyce Hu; Mehrdad Matloubian; Matthew F Krummel
Journal:  Nat Immunol       Date:  2013-03-10       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.